Jun
2026
Shanghai New International Expo Center
Visit us
stand W4E80, Biotech
Zone
Shenzhen Mellowhope Pharm Industrial Co., Ltd.
Exhibitor at CPHI & PMEC China 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:2
-
Employees:100 - 249
Company types
Primary activities
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand W4E80, Biotech
Products Featured at CPHI & PMEC China 2026
-
Product Meningococcal Polysaccharide Vaccine (Group A/C/Y/W135)
[Dosage Form]: Freeze-dried powder for Injection [Indication]: The vaccine is indicated for active immunization against invasive meningococcal disease caused by Neisseria meningitis group A, group C, group Y and group W135. [Specification]: Each 0.5 ml dose of reconstituted vaccine contains 50 Mug of each ... -
Product Trastuzumab Injection
[Dosage form]: Liquid for injection [Specification]: 150mg/vial; 440mg/vial (pipeline)
[Indication]: Indicated for Metastatic breast cancer, Early breast cancer, Metastatic gastric cancer.
[Administration]: Intravenous injection
[Shelf life]: 24 months -
Product Adalimumab Injection
[Dosage form]: Liquid for injection [Specification]: 40mg/0.8ml, pre-filled syringe [Indication]: Used to treat many inflammatory conditions in adults, such as Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Ulcerative Colitis, Pl... -
Product 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
[Dosage form]: Suspension for injection [Specification]: 0.5 ml/dose
[Indication]: Protect infants over 2 months, young children, and adults against disease caused by the bacterium Streptococcus pneumonia.
[Administration]: Intramuscular injection
[Storage temperature (℃)]: ... -
Product Bevacizumab Injection
English Name: Bevacizumab Injection
Dosage Form: Liquid for injection
Specification(Dosage): 100mg/vial; (400mg is still in pipeline)
Indication: Indicated for Metastatic Colorectal Cancer, Advanced, Metastatic, or recurrent Non-small-cell Lung Cancer. ...




